CARY, N.C. — December 15, 2014 — Medfusion, a leading provider of patient portal software, announced the appointment of Vern Davenport as chief executive officer (CEO). As CEO, Davenport will further leverage his operational and industry expertise to provide direction and leadership to the organization. Davenport previously held the position of president of Medfusion.

Steve Malik, founder, will remain with the company as executive chairman, where he will focus on both corporate and financial strategy. In addition, Malik will concentrate on innovation initiatives for Medfusion’s business today, and in the future.

“When I re-acquired Medfusion in 2013, I wanted to find an experienced, respected, and committed leadership team that shared my passion for healthcare and the growth of this business,” said Steve Malik. “Vern assuming the role of CEO was a planned and well-deserved promotion. There is no better person to lead Medfusion as we continue to move forward in this exciting time of rapid change that will present the opportunity to solve large problems for patients and providers.”

Since joining Medfusion, Davenport has been instrumental in the growth of the organization, its portal, and other evolving business units. This year, the company achieved the milestone of reaching 10 million patients on the portal, dramatically increased customer satisfaction scores, and significantly expanded market opportunities by delivering advanced integration with major electronic health records (EHR).

Davenport has also focused on expanding the Medfusion team to better serve the growing customer base. Since his hire, Medfusion has doubled the number of employees across multiple departments and was voted one of the 50 “Best Places to Work in the Triangle” for 2014 by the Triangle Business Journal. In connection with assuming the role of CEO, Davenport led a $5 million round of additional financing for Medfusion.

“When Steve founded Medfusion, he had a vision for where healthcare was going and the gaps that were currently in existence,” said Vern Davenport. “Since I joined the company, Steve and I have been working closely to re-platform the organization, and we are now poised for significant growth and continued success. Allowing Steve the opportunity to step back from day-to-day management of the company to focus on other Medfusion initiatives will only increase our momentum.”